Table 4.
Populations | Number donors | % F/F | 95% confidence limits+ | ||
---|---|---|---|---|---|
F/F | F/V or V/V | All | |||
CFS patients | 10 | 1 | 11 | 90.9 | 58.7–99.8% |
Non-CFS family members | 18 | 4 | 22 | 81.8 | 59.7 –94.8% |
Unrelated healthy donors | 3 | 13 | 16 | 18.8 | 4–45.6% |
CFS family parents, highest possible %F/F# | 8 | 2 | 10 | 80@ | 44.4–97.5% |
CFS family parents, lowest possible %F/F# | 5 | 5 | 10 | 50.0 | 18.7–81.3% |
Reference Group: Northern European origin^ | 385 | 534 | 919 | 41.9 | 38.7–45.2% |
Binomial “exact” calculations of the confidence intervals for proportions
Ten CFS family parents: living 5 F/F, 2 F/V, and 0 V/V; 3 deceased.
P <0.05, for 8 or more F/F, calculated with 0.419 as the probability that a parent will be F/F.
From reference (40); the FCGR3A allele encoding V158 CD16A had a frequency of 0.363.